Which funds bought or sold LLY in Q3 2026?
Eli Lilly & Co. 12 funds bought, 23 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$2.0B. See also what famous investors say about LLY.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Fidelity+$1.7B
- JPMorgan+$1.4B
- GQGNEW+$878M
- Fisher Investments+$417M
- Two Sigma+$299M
- Invesco+$154M
- Legal & General+$134M
- CalPERS+$132M
- Point72+$122M
- Adage+$117M
- Capital Research−$4.5B
- Goldman Sachs−$919M
- QRT−$400M
- Polen−$344M
- AllianceBernstein−$327M
- Citadel−$305M
- Bank of America−$283M
- Susquehanna−$258M
- RBC−$254M
- Schonfeld−$248M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (12)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Fidelity Asset manager | Added+5.3% | +$1.7B | $34.7B |
| JPMorgan Bank & broker | Added+9.4% | +$1.4B | $16.3B |
| GQG Growth / crossover | New | +$878M | $878M |
| Fisher Investments Asset manager | Added+7.1% | +$417M | $6.3B |
| Two Sigma Quant & multi-strategy | Added+317.6% | +$299M | $393M |
| Invesco Asset manager | Added+3.6% | +$154M | $4.4B |
| Legal & General Asset manager | Added+2.3% | +$134M | $6.1B |
| CalPERS Sovereign & pension | Added+7.9% | +$132M | $1.8B |
| Point72 Quant & multi-strategy | Added+1003.7% | +$122M | $134M |
| Adage Hedge fund | Added+13.9% | +$117M | $957M |
| ARK Growth / crossover | Added+39.6% | +$35M | $125M |
| Temasek Sovereign & pension | Added+2.8% | +$5M | $180M |
Sold (23)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Capital Research Asset manager | Trimmed-18.6% | −$4.5B | $19.7B |
| Goldman Sachs Bank & broker | Trimmed-10.4% | −$919M | $7.9B |
| QRT Quant & multi-strategy | Trimmed-99.8% | −$400M | $959K |
| Polen Growth / crossover | Trimmed-44.6% | −$344M | $427M |
| AllianceBernstein Asset manager | Trimmed-6.6% | −$327M | $4.6B |
| Citadel Quant & multi-strategy | Trimmed-27.9% | −$305M | $789M |
| Bank of America Bank & broker | Trimmed-2.2% | −$283M | $12.8B |
| Susquehanna Quant & multi-strategy | Trimmed-75.3% | −$258M | $84M |
| RBC Bank & broker | Trimmed-5% | −$254M | $4.8B |
| Schonfeld Quant & multi-strategy | Trimmed-89.4% | −$248M | $30M |
| D. E. Shaw Quant & multi-strategy | Trimmed-36.3% | −$208M | $366M |
| Schwab Index giant | Trimmed-2.6% | −$182M | $6.8B |
| Amundi Asset manager | Trimmed-3.2% | −$177M | $5.4B |
| Jennison Growth / crossover | Trimmed-2.7% | −$173M | $6.1B |
| UBS Bank & broker | Trimmed-3.8% | −$171M | $4.3B |
| Arrowstreet Quant & multi-strategy | Trimmed-54% | −$156M | $133M |
| Marshall Wace Quant & multi-strategy | Trimmed-33.3% | −$129M | $258M |
| Hudson Bay Quant & multi-strategy | Sold out | −$120M | — |
| CPP Investments Sovereign & pension | Trimmed-4% | −$80M | $1.9B |
| Tudor Hedge fund | Trimmed-76.5% | −$27M | $8M |
| Duquesne Family office & foundation | Trimmed-69.3% | −$10M | $4M |
| Sands Capital Growth / crossover | Trimmed-6.9% | −$4M | $49M |
| Dodge & Cox Value investor | Trimmed-3% | −$1M | $46M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.